数字符号替换试验
生命历程法
认知功能衰退
认知
体质指数
队列
医学
队列研究
人口学
血压
内科学
老年学
心理学
疾病
发展心理学
精神科
痴呆
社会学
病理
替代医学
安慰剂
作者
Kristine Yaffe,Eric Vittinghoff,Tina Hoang,Karen A. Matthews,Sherita Hill Golden,Adina Zeki Al Hazzouri
出处
期刊:Neurology
[Ovid Technologies (Wolters Kluwer)]
日期:2021-03-17
卷期号:96 (17)
被引量:43
标识
DOI:10.1212/wnl.0000000000011747
摘要
Objective
Cardiovascular risk factors (CVRFs) are associated with increased risk of cognitive decline, but little is known about how early adult CVRFs and those across the life course might influence late-life cognition. To test the hypothesis that CVRFs across the adult life course are associated with late-life cognitive changes, we pooled data from 4 prospective cohorts (n = 15,001, ages 18–95). Methods
We imputed trajectories of body mass index (BMI), fasting glucose (FG), systolic blood pressure (SBP), and total cholesterol (TC) for older adults. We used linear mixed models to determine the association of early adult, midlife, and late-life CVRFs with late-life decline on global cognition (Modified Mini-Mental State Examination [3MS]) and processing speed (Digit Symbol Substitution Test [DSST]), adjusting for demographics, education, and cohort. Results
Elevated BMI, FG, and SBP (but not TC) at each time period were associated with greater late-life decline. Early life CVRFs were associated with the greatest change, an approximate doubling of mean 10-year decline (an additional 3–4 points for 3MS or DSST). Late-life CVRFs were associated with declines in early late life (<80 years) but with gains in very late life (≥80 years). After adjusting for CVRF exposures at all time periods, the associations for early adult and late-life CVRFs persisted. Conclusions
We found that imputed CVRFs across the life course, especially in early adulthood, were associated with greater late-life cognitive decline. Our results suggest that CVRF treatment in early adulthood could benefit late-life cognition, but that treatment in very late life may not be as helpful for these outcomes.
科研通智能强力驱动
Strongly Powered by AbleSci AI